FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * EW HEALTHCARE PARTNERS FUND 2, L.P. 2. Issuer Name and Ticker or Trading Symbol TELA Bio, Inc. [ TELA ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
_____ Officer (give title below)    __X__ Other (specify below)
See footnote 2
(Last)         (First)         (Middle)
21 WATERWAY AVENUE, SUITE 225
3. Date of Earliest Transaction (MM/DD/YYYY)
9/15/2021
(Street)
THE WOODLANDS, TX 77380
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
9/17/2021 
6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.001 per share  9/15/2021 (3)   P    10000  A $12.43  1832048  I  See footnotes (1)(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 4,045 shares of the amount shown above and Fund 2-A purchased 5,955 shares of the amount shown above. Fund 2 now holds a total of 761,160 shares and Fund 2-A now holds a total of 1,070,888 shares of the Issuer.
(2)  EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.
(3)  This Amended Form 4 is filed only to correct the date set forth in the original Form 4 filed on September 17, 2021. No other change has been made to the original Form 4 filed on September 17, 2021 relating to the trade made on September 15, 2021.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
EW HEALTHCARE PARTNERS FUND 2, L.P.
21 WATERWAY AVENUE, SUITE 225
THE WOODLANDS, TX 77380



See footnote 2
EW HEALTHCARE PARTNERS FUND 2-A, L.P.
21 WATERWAY AVENUE, SUITE 225
THE WOODLANDS, TX 77380



See footnote 2
EW Healthcare Partners Fund 2 GP, L.P.
21 WATERWAY AVENUE, SUITE 225
THE WOODLANDS, TX 77380

X

EW Healthcare Partners Fund 2-UGP, LLC
21 WATERWAY AVENUE, SUITE 225
THE WOODLANDS, TX 77380

X


Signatures
EW HEALTHCARE PARTNERS FUND 2, L.P., By: EW Healthcare Partners Fund 2 GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter 9/17/2021
**Signature of Reporting Person Date
EW HEALTHCARE PARTNERS FUND 2-A, L.P., By: EW Healthcare Partners Fund 2 GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter 9/17/2021
**Signature of Reporting Person Date
EW HEALTHCARE PARTNERS FUND 2 GP, L.P., By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in- Fact, /s/ Martin P. Sutter 9/17/2021
**Signature of Reporting Person Date
EW HEALTHCARE PARTNERS FUND 2-UGP, LLC, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter 9/17/2021
**Signature of Reporting Person Date
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Sep 2021 to Oct 2021 Click Here for more TELA Bio Charts.
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Oct 2020 to Oct 2021 Click Here for more TELA Bio Charts.